
Oncology Today with Dr Neil Love
Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity
1 tim 1 min•29 oktober 2026
Om avsnittet
Featuring an interview with Dr Erica Mayer, including the following topics:
- Risk Assessment and Genomic Assays for Hormone Receptor (HR)-Positive, HER2-Negative Localized Breast Cancer (0:00)
- Investigator Survey Results on Risk Assessment and Genomic Assays (20:07)
- Adjuvant CDK4/6 Inhibitors for High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (24:30)
- Investigator Survey Results on Adjuvant CDK4/6 Inhibitors (30:42)
- Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (32:07)
- Investigator Survey Results on Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (37:44)
- Adjuvant Oral Selective Estrogen Receptor Degraders (SERDs) for HR-Positive, HER2-Negative Localized Breast Cancer (39:05)
- Investigator Survey Results on Adjuvant Oral SERDs (43:02)
- Discussion of Questions from the Community (45:00)
Oncology Today with Dr Neil Love med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.